BlackRock Inc. - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$66,783,724
+27.1%
2,113,409
+4.1%
0.00%
+100.0%
Q2 2023$52,525,802
+27.9%
2,030,375
+18.7%
0.00%0.0%
Q1 2023$41,070,020
-1.4%
1,709,826
-20.0%
0.00%0.0%
Q4 2022$41,665,204
+13.4%
2,136,677
+22.1%
0.00%0.0%
Q3 2022$36,754,000
+35.3%
1,749,349
+25.3%
0.00%0.0%
Q2 2022$27,166,000
+57.6%
1,396,012
+78.3%
0.00%
Q1 2022$17,238,000
+40.0%
782,830
+1.4%
0.00%
Q4 2021$12,316,000
+1.3%
772,098
+26.5%
0.00%
Q3 2021$12,162,000
+15.7%
610,565
+0.5%
0.00%
Q2 2021$10,508,000
-30.3%
607,734
-20.1%
0.00%
Q1 2021$15,078,000
+55.6%
760,839
+37.1%
0.00%
Q4 2020$9,689,000
+19.2%
554,889
+31.5%
0.00%
Q3 2020$8,131,000
-1.8%
421,969
-0.8%
0.00%
Q2 2020$8,281,000
+130.5%
425,538
+65.7%
0.00%
Q1 2020$3,593,000
-19.1%
256,735
+41.7%
0.00%
Q4 2019$4,442,000
+1161.9%
181,169
+416.8%
0.00%
Q3 2019$352,00035,0550.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,470,392$204,464,38713.58%
NEA Management Company, LLC 2,186,243$69,085,2795.34%
TANG CAPITAL MANAGEMENT LLC 1,137,107$35,932,5815.07%
BOONE CAPITAL MANAGEMENT LLC 389,791$12,317,3963.89%
Highlander Partners, L.P. 122,980$3,886,1683.84%
BVF INC/IL 4,370,024$138,092,7583.72%
Prosight Management, LP 353,508$11,170,8533.54%
Novo Holdings A/S 1,500,000$47,400,0003.50%
Nicholas Investment Partners, LP 1,199,366$37,899,9662.83%
Eventide Asset Management 3,958,579$125,091,0972.25%
View complete list of MIRUM PHARMACEUTICALS INC shareholders